Active Ingredients: Lente (porcine* zinc) insulin *Do not administer Vetsulin to animals with a systemic allergy to pork or pork products. Inactive ingredients (per mL) Zinc (as chloride) 0.08 mg, Sodium acetate trihydrate 1.36 mg, Sodium chloride 7 mg, Methylparaben (preservative) 1 mg. pH is adjusted with hydrochloric acid and⁄or sodium hydroxide.

Usage: *For complete product information, please review the full prescribing information in the manufacturer package insert. Vetsulin Insulin should be administered subcutaneously (injected under the skin) as directed by your veterinarian. Please consult your veterinarian before making any changes or discontinuing the prescribed dosing schedule. Injectable medications require needles, syringes, and a designated sharps disposal container. These are not included with the medication and must be purchased separately. Please consult your veterinarian for guidance regarding appropriate needle and syringe sizes for your pet. For general injectable use (aseptic technique): Aseptic technique refers to a set of practices designed to minimize the risk of contamination and infection during medical procedures. These practices can also be applied to the handling and administration of injectable medications to your pet to help reduce the risk of post–injection bacterial infections. Wash your hands thoroughly with soap and water before and after administration. Use a new, sterile needle and syringe for each injection. Needles and syringes should never be reused. Do not touch the needle, syringe tip, or vial stopper (once it has been wiped with alcohol) to any surface to avoid contamination. Adequately clean and disinfect the vial stopper with an alcohol wipe, then allow it to dry before inserting the sterile needle⁄syringe. Withdraw and administer the prescribed dose as directed by your veterinarian. Dispose of the needle⁄syringe immediately after use into a proper sharps disposal container. Manufacturer Dosage and Administration: FOR SUBCUTANEOUS INJECTION IN DOGS AND CATS ONLY USE OF A SYRINGE OTHER THANA U–40 SYRINGE WILL RESULT IN INCORRECT DOSING. Shake the vial thoroughly until a homogeneous, uniformly milky suspension is obtained. Foam on the surface of the suspension formed during shaking should be allowed to disperse before the product is used and, if required, the product should be gently mixed to maintain a homogeneous, uniformly milky suspension before use. Clumps or white particles can form in insulin suspensions: do not use the product if visible clumps or white particles persist after shaking thoroughly.

Missed Doses: Administer the dose as soon as possible. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule. Do not administer more medication than prescribed or two doses at once. If you have questions about your pet's prescribed dosing schedule (e.g., timing, interval), please consult your veterinarian.

Side Effects: *For complete information on this product's side effects and how tomanage them, please refer to the manufacturer's package insert and Owner Information Sheet. The most common side effect of this medication is hypoglycemia (low blood sugar). Signs of hypoglycemia may occur suddenly, and may include weakness⁄lethargy, behavioral changes, muscle twitching, decreased coordination (e.g., stumbling⁄falling), seizures, and coma. Always be prepared for an unexpected hypoglycemic event; a source of real sugar (e.g., food, oral dextrose) should be kept on hand and offered to your pet if hypoglycemia occurs. Contact your veterinarian as soon as possible. Prolonged hyperglycemia can result in severe side effects including seizures, coma, and death. If your pet falls unconscious or has a seizure, this is a medical emergency– seek emergency veterinary attention immediately. In some cases, injection site reactions (including lumps or thickening of the skin) have been reported. Rotating injection sites may help prevent these reactions. Notify your veterinarian if your pet experiences any of the effects described above, or if you notice any other side effects that are persistent or troublesome. If you notice anything unusual, please consult your veterinarian.

Precautions: *For complete product information including warnings and precautions, please refer to the manufacturer package insert. This is a U–40 insulin; only compatible (U–40) syringes should be used to administer this product. Inspect the vial before each use. Do NOT use this medication if the suspension changes in appearance (e.g., color, clumping, presence of large visible particles). These may be signs that the product is no longer fit for use. For use in animals only. Keep out of the reach of children. Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for 15 minutes. Accidental injection may cause clinical hypoglycemia. In case of accidental injection, seek medical attention immediately. Exposure to product may induce a local or systemic allergic reaction in sensitized individuals. Do NOT administer this medication during periods of hypoglycemia. Any change in insulin should be made cautiously and only under a veterinarian's supervision. Animals presenting with severe ketoacidosis, anorexia, lethargy, and⁄or vomiting should be stabilized with short–acting insulin and appropriate supportive therapy until their condition is stabilized. As with all insulin products, careful patient monitoring for hypoglycemia and hyperglycemia are essential to attain and maintain adequate glycemic control and prevent associated complications. The safety and effectiveness of Vetsulin in breeding, pregnant, and lactating dogs and cats has not been evaluated. Discuss the risks of using this medication with your veterinarian prior to use if your pet is in one of these groups. The safety and effectiveness of Vetsulin in puppies and kittens has not been evaluated. Do not administer Vets